Table 2 Attainment of quality-of-care measures by cause of ESRD (lupus nephritis, other glomerulonephritis, and all other causes) and by incident year, among U.S. ESRD patients initiating treatment 7/05–9/11

Pre-ESRD nephrology care, %

All ESRD (n = 594,556)

65.7%

65.9%

65.6%

65.0%

65.0%

65.5%

65.9%

67.7%

<0.001

ESRD attributed to:

Lupus nephritis (n = 5,939)

71.1%

72.2%

70.2%

71.7%

70.3%

73.1%

68.9%

72.3%

0.96

Other glomerulonephritis (n = 48,031)

69.3%

69.3%

69.1%

67.7%

69.2%

69.0%

70.4%

71.2%

0.002

All other causes (n = 540,586)

65.3%

65.5%

65.2%

64.6%

64.6%

65.1%

65.5%

67.4%

<0.001

Informed of transplant options, %

All ESRD (n = 392,513)

78.9%

76.9%

76.2%

76.6%

78.0%

80.5%

81.4%

82.4%

<0.001

ESRD attributed to:

Lupus nephritis (n = 5,619)

84.8%

87.0%

82.6%

82.6%

84.8%

85.9%

86.5%

85.8%

0.07

Other glomerulonephritis (n = 32,325)

83.6%

82.3%

82.1%

81.6%

83.6%

84.5%

85.1%

87.0%

<0.001

All other causes (n = 354,569)

78.3%

76.1%

75.5%

76.0%

77.4%

80.1%

81.1%

82.0%

<0.001

Placement on the kidney transplant waitlist, events/1000 p-y

All ESRD (n = 392,513)

97

83

88

91

99

114

122

95

<0.001

ESRD attributed to:

Lupus nephritis (n = 5,619)

206

194

177

208

210

230

263

180

0.07

Other glomerulonephritis (n = 32,325)

203

162

181

190

211

240

277

232

<0.001

All other causes (n = 354,569)

86

74

78

80

88

102

108

82

<0.001

Permanent vascular access used or in place at ESRD start, %

All ESRD (n = 616,025)

35.9%

37.4%

36.7%

35.4%

34.3%

35.1%

36.4%

37.4%

0.89

ESRD attributed to:

Lupus nephritis (n = 5,624)

24.4%

22.3%

25.7%

23.9%

23.5%

24.3%

25.5%

25.3%

0.45

Other glomerulonephritis (n = 41,824)

37.7%

40.3%

38.6%

37.4%

36.1%

36.7%

37.1%

39.6%

0.83

All other causes (n = 568,577)

35.9%

37.3%

36.7%

35.4%

34.2%

35.0%

36.5%

37.4%

0.11